Jan 07, 2011, 05.05 PM IST
With plans of creeping in share acquisition, promoters of Elder Pharmaceuticals have entered in talks with some Japanese companies to supply bulk drugs. The company would start marketing the products in Japan in the next three to four months.
The pharma major recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. Talking to CNBC-TV18, director Alok Saxena said that the accreditation would help enter grow in the Japanese pharma market.
Elder Pharma stock price
On December 11, 2013, Elder Pharmaceuticals closed at Rs 318.20, up Rs 32.50, or 11.38 percent. The 52-week high of the share was Rs 436.00 and the 52-week low was Rs 202.15.
The company's trailing 12-month (TTM) EPS was at Rs 23.63 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 13.47. The latest book value of the company is Rs 378.73 per share. At current value, the price-to-book value of the company is 0.84.
Action in Elder Pharmaceuticals
Video of the day
Dec 11 2013, 09:54
- in Business
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.